Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered <i>In Vitro</i> Models of Ovarian Cancer-Reference-Cited by-同舟云学术

Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer

Published:2024-04-01 Issue: Volume: Page:
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

VandenHeuvel Sabrina N.¹,Chau Eric²,Mohapatra Arpita¹,Dabbiru Sameera¹,Roy Sanjana¹,O’Connell Cailin²³,Kamat Aparna⁴⁵⁶,Godin Biana¹²⁵⁶,Raghavan Shreya A.¹^ORCID

Affiliation:

1. Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States

2. Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030, United States

3. School of Engineering Medicine, Texas A&M University, 1020 Holcombe Boulevard, Houston, Texas 77030, United States

4. Division of Gynecologic Oncology, Houston Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, United States

5. Department of Obstetrics and Gynecology, Houston Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, United States

6. Houston Methodist Neal Cancer Center, 6445 Main Street, Houston, Texas 77030, United States

Funder

Texas A and M Engineering Experiment Station, Texas A and M University

National Institutes of Health

Dr. and Mrs. Kaplan Gynecologic Cancer Fund

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00076

Reference67 articles.

1. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment

2. The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment

3. High-throughput approaches for precision medicine in high-grade serous ovarian cancer

4. Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment

5. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients